Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions (Englisch)
- Neue Suche nach: Makley, Leah N.
- Neue Suche nach: Gestwicki, Jason E.
- Neue Suche nach: Makley, Leah N.
- Neue Suche nach: Gestwicki, Jason E.
In:
Chemical Biology & Drug Design
;
81
, 1
;
22-32
;
2013
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions
-
Beteiligte:Makley, Leah N. ( Autor:in ) / Gestwicki, Jason E. ( Autor:in )
-
Erschienen in:Chemical Biology & Drug Design ; 81, 1 ; 22-32
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:11 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 81, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Beyond the Hundred Dollar Genome – Drug Discovery FuturesSelwood, David L. et al. | 2013
- 5
-
Patient‐Specific Modelling in Drug Design, Development and Selection Including its Role in Clinical Decision‐MakingShublaq, Nour / Sansom, Clare / Coveney, Peter V. et al. | 2013
- 13
-
Putative Impact of RNA Editing on Drug DiscoveryDecher, Niels / Netter, Michael F. / Streit, Anne K. et al. | 2013
- 22
-
Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein InteractionsMakley, Leah N. / Gestwicki, Jason E. et al. | 2013
- 33
-
The Future of Virtual Compound ScreeningHeikamp, Kathrin / Bajorath, Jürgen et al. | 2013
- 41
-
Accounting for Receptor Flexibility and Enhanced Sampling Methods in Computer‐Aided Drug DesignSinko, William / Lindert, Steffen / McCammon, J. Andrew et al. | 2013
- 50
-
Advances in the Prediction of Protein–Peptide Binding Affinities: Implications for Peptide‐Based Drug DiscoveryAudie, Joseph / Swanson, Jon et al. | 2013
- 61
-
Back to the Future: Can Physical Models of Passive Membrane Permeability Help Reduce Drug Candidate Attrition and Move Us Beyond QSPR?Swift, Robert V. / Amaro, Rommie E. et al. | 2013
- 72
-
Optimization of CD4/gp120 Inhibitors by Thermodynamic‐Guided Alanine‐Scanning MutagenesisLiu, Yingyun / Schön, Arne / Freire, Ernesto et al. | 2013
- 79
-
Potential of Anti‐Cancer Therapy Based on Anti‐miR‐155 Oligonucleotides in Glioma and Brain TumoursPoltronieri, Palmiro / D’Urso, Pietro I. / Mezzolla, Valeria / D’Urso, Oscar F. et al. | 2013
- 85
-
Inside Out: Targeting NHE1 as an Intracellular and Extracellular Regulator of Cancer ProgressionProvost, Joseph J. / Wallert, Mark A. et al. | 2013
- 102
-
Stress‐Related Mitochondrial Components and Mitochondrial Genome as Targets of Anticancer TherapyGiannattasio, Sergio / Guaragnella, Nicoletta / Arbini, Arnaldo A. / Moro, Loredana et al. | 2013
- 113
-
Antibody‐Drug Conjugates for the Treatment of CancerFlygare, John A. / Pillow, Thomas H. / Aristoff, Paul et al. | 2013
- 122
-
Prospects in the Total Synthesis of Protein TherapeuticsChalker, Justin M. et al. | 2013
- 136
-
The Future of Peptide‐based DrugsCraik, David J. / Fairlie, David P. / Liras, Spiros / Price, David et al. | 2013
- 148
-
Peptide Scanning for Studying Structure‐Activity Relationships in Drug DiscoveryJamieson, Andrew G. / Boutard, Nicolas / Sabatino, David / Lubell, William D. et al. | 2013
- i
-
Issue Information| 2013